PHI with Salpingitis
How does this condition affect your private health insurance?
Eileiterentzündung, also known as Salpingitis, is an inflammation of the fallopian tubes, often caused by bacterial infections ascending from the vagina or cervix. Common culprits include sexually transmitted infections like Chlamydia and Gonorrhea, as well as other bacteria. Symptoms can range from mild pelvic pain, fever, and abnormal vaginal discharge to severe abdominal pain and nausea. If left untreated, it can lead to serious complications such as abscess formation, chronic pelvic pain, infertility due to scarring and blockage of the fallopian tubes, and an increased risk of ectopic pregnancy. Early diagnosis and antibiotic treatment are crucial to prevent these long-term consequences.
PKV Risk Assessment
However, some specialized PHI providers may insure you with a surcharge of up to 10%.
Impact on Your Insurance Policy
Duration of Illness (Initial)
Typically several days to a few weeks with appropriate treatment.
Duration of Illness (Lifetime)
Can be a one-time acute event, but recurrent infections are possible, and chronic pelvic pain can persist.
Cost of Treatment (Initial)
Varies from €50-€300 for outpatient antibiotics to €1,000-€5,000+ for hospitalization and IV antibiotics.
Cost of Treatment (Lifetime)
Can range from hundreds for acute episodes to tens of thousands if complications like infertility treatment (IVF) or surgery for adhesions occur.
Mortality Rate
Very low with modern medical care, but can increase if peritonitis or sepsis develops from ruptured abscesses (less than 0.1%).
Risk of Secondary Damages
High, particularly if untreated or recurring. Risks include infertility (10-30%), ectopic pregnancy (6-10x increased risk), chronic pelvic pain (20-30%), and tubo-ovarian abscess (5-15%).
Probability of Full Recovery
High with prompt and adequate antibiotic treatment (70-90% for acute episodes). However, some degree of tubal damage may remain, affecting fertility.
Underlying Disease Risk
High. Often associated with sexually transmitted infections (Chlamydia, Gonorrhea) in 40-60% of cases, recent gynecological procedures, or IUD insertion.